Perfuze

Perfuze company information, Employees & Contact Information

Explore related pages

Related company profiles:

Neurovascular medtech startup

Company Details

Employees
44
Founded
-
Address
Galway, Galway H91h2y0, Ie
Email
in****@****uze.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Galway, Galway
Looking for a particular Perfuze employee's phone or email?

Perfuze Questions

News

Perfuze Presents Preliminary Results from MARRS Pivotal Trial at SNIS, Highlighting Millipede - Business Wire

Perfuze Presents Preliminary Results from MARRS Pivotal Trial at SNIS, Highlighting Millipede Business Wire

Perfuze celebrates a ‘major milestone’ for new-look stroke catheter - Cardiovascular Business

Perfuze celebrates a ‘major milestone’ for new-look stroke catheter Cardiovascular Business

Perfuze Announces Completion of Enrollment in Pivotal US Clinical Study and Appointment of Joe Rotger as Executive Vice President of Sales - Business Wire

Perfuze Announces Completion of Enrollment in Pivotal US Clinical Study and Appointment of Joe Rotger as Executive Vice President of Sales Business Wire

Galway’s Perfuze raises €22m, gets FDA clearance for catheter - Silicon Republic

Galway’s Perfuze raises €22m, gets FDA clearance for catheter Silicon Republic

Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding - Business Wire

Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding Business Wire

Late-breaking MARRS trial data reveal 61% first-pass effect rate with Perfuze’s Millipede system - NeuroNews International

Late-breaking MARRS trial data reveal 61% first-pass effect rate with Perfuze’s Millipede system NeuroNews International

Perfuze wins FDA nod for access catheter, raises $24M - MassDevice

Perfuze wins FDA nod for access catheter, raises $24M MassDevice

Perfuze® Announces FDA Clearances for Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment - BioSpace

Perfuze® Announces FDA Clearances for Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment BioSpace

FDA clears Perfuze’s Zipline access catheter for stroke treatment - Medical Device Network

FDA clears Perfuze’s Zipline access catheter for stroke treatment Medical Device Network

Perfuze: €22 Million Raised And Clearance Received For Zipline Access Catheters - Pulse 2.0

Perfuze: €22 Million Raised And Clearance Received For Zipline Access Catheters Pulse 2.0

FDA grants breakthrough status to Perfuze stroke device - MedTech Dive

FDA grants breakthrough status to Perfuze stroke device MedTech Dive

Irish medtech company Perfuze raises €22.5m for new stroke treatment - The Irish Times

Irish medtech company Perfuze raises €22.5m for new stroke treatment The Irish Times

‘We’re going to compete against the big boys’: Galway’s Perfuze prepares for US stroke tech launch - Business Post

‘We’re going to compete against the big boys’: Galway’s Perfuze prepares for US stroke tech launch Business Post

Perfuze completes enrolment in pivotal US study, appoints new executive vice president of sales - NeuroNews International

Perfuze completes enrolment in pivotal US study, appoints new executive vice president of sales NeuroNews International

Perfuze announces US FDA clearance and first US clinical use of Millipede 088 access catheter - NeuroNews International

Perfuze announces US FDA clearance and first US clinical use of Millipede 088 access catheter NeuroNews International

Perfuze Announces FDA Clearance and First U.S. Clinical Use of Millipede 088 Access Catheter - Business Wire

Perfuze Announces FDA Clearance and First U.S. Clinical Use of Millipede 088 Access Catheter Business Wire

Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment - Business Wire

Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment Business Wire

Perfuze announces CE mark and treats first patients with Millipede 088 catheter - NeuroNews International

Perfuze announces CE mark and treats first patients with Millipede 088 catheter NeuroNews International

Top Perfuze Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant